China Academic Journal Electronic Publishing House. All rights reserved.
|
|
- Alison Chase
- 5 years ago
- Views:
Transcription
1 NatlMed J China,May 9, 2006, Vol 86, No B B(BNP) ,BNP (LVEF) 40% ( n = 111)> 40%( n = 132) ;(NYHA, n = 110) (NYHA, n = 133) BNP, BNP(29210 ng/l vs 1719 ng/l, P < 01001), LVEF40% LVEF > 40%( ng/l vs ng/l, P < 01001), (57910 ng/l vs 8418 ng/l, P < 01001)BNP(AUC) = LVEF40%(AUC = 01989) (AUC = 01991)(AUC = 01941)AUC,9010 ng/l, LVEF40% 9819% 9811%9815%, 6415% 9410% 9615%5010 ng/l,lvef > 40%8810% 8417%, 7216%7211% BNPLVEF 9010 ng/l LVEF40%; 5010 ng/llvef > 40% ; The clin ica l va lue of B2type na tr iuretic peptide in the d iagnosis of left heart fa ilurezhao Xue2 yan, YAN G Yue2jin, ZHANG J ian, DAN G A i2m in, N I X in2hai, HUANG J ie, KANG Sheng, MA W ei2hua, ZHAO D ong2yun. D epartm ent of Cardiology, Cardiovascular Institute and Fuw ai Hospital, Chinese A cadem y of M edical Sciences and Peking U nion M edical College, B eijing , China Corresponding author: YANG Yue2jin, Em ail: fuw aihospital. org AbstractO bjectiveto evaluate the diagnostic value of B2type natriuretic pep tide (BNP) in the diagnosis of left heart failure (HF) or left ventricular systolic dysfunction. M ethodssamp les of peripheral venous blood were collected from 243 consecutive patients with left HF and 111 normal controls ( control group, CG) to measured BNP level with fluorescence immunoassay method. The patients with left HF were divided into 2 group s: those with the left ventricular ejection fraction (LVEF) 40% ( n = 111) and those with the LVEF > 40% ( n = 132) according to the level of LVEF; or into 2 group s: compensated heart failure group (CHF group, at NYHA grade 2, n = 110) and decompensated heart failure group (DHF group, at NYHA grade 2, n = 133) according to the New York Heart A ssociation (NYHA ) functional class. ResultsThe p lasma level of BNP of the left HF group was ng/l, significantly higher than that of the CG(1719 ng/l, P < ). The p lasma BNP of the group with the LVEF40% was ng/l, significantly than that of the group with the LVEF > 40% (13815 ng/l, P < ). The p lasma BNP of the DHF group was ng/l, significantly higher than that of the of the CHF group (8418 ng/l, P < ). The values of area under the curve (AUC) of receiver operator characteristic curve were all > 0. 9 in the diagnosis of p resence of HF (AUC = ), HF with the LVEF40% (AUC = ), and DHF (AUC = ), and in the differential diagnosis between CHF and DHF (AUC = ). W hen pg/m l was used as cutoff value to diagnose left HF, heart failure with the LVEF40%, and decompensation, the positive p redictive value ( PPV ) were 98. 9%, 98. 1%, and 98. 5% respectively, and the negative p redictive value (NPV) were 64. 5%, 94. 0%, and 96. 5% respectively. W hen pg/m l was used as the cutoff value to diagnose HF with the LVEF > 40% and compensated heart failure, the PPV were 88. 0% and 84. 7%, the NPV were 72. 6% and 72. 1% respectively. ConclusionThe diagnostic value of BNP is : ( ) : , :, YYJ@ fuwaihosp ital. org
2 NatlMed J China,May 9, 2006, Vol 86, No117 high for the diagnosis of more severely impaired LVEF and decompensated heart failure with pg/m l as the cutoff value, and if pg/m l is used as the cutoff value, the value is also good for the diagnosis of HF with the LVEF > 40% and compensated heart failure. Key words Heart failure; B rain natriuretic pep tide B(B2type natriuretic pep tide, BNP) ( natriuretic pep tide, NP), [ 1 ], BNP, BNP [ 2 ],BNP [ 3 ],, BNP BNP,BNP 1. : , 14 91, , 255 (7210% ),99(2810% ) 243 (NYHA 35 ) 111 ( 4414% ), ( 2519% ) ( 1619% ) (1218% ),, (LVEF) : LVEF 40%111LVEF > 40%132; (NYHA2) 110 (NYHA2) :,,,BNP, BNP 48 h, X BNP: EDTA,( triage, biosite)bnp 1 ng/l5000 ng/l (0129 pmol/l pmol/l) 3. : gx S gx BNP, BNP, t 2,,q ( receiver operator characteristic curve; ROC ),ROC(AUC), AUC, SPSS :,( P < 01001), ( P < 01001), (LVEF) ( P < 01001), BNP16LVEF40% LVEF > 40%, LVEF40% ( P < 01001),( P < 0105), ( P < 01001), LVEF( P < 01001), BNP(1, 2, P < 01001), ( P < 0105 ), ( P < 01001), LVEF( P < 01001), BNP (2, P < 01001) 2. BNP:BNP 16( P < 01001) NYHA BNP (2, 3, P < 01001), ( P > 0105) NYHA,BNP ( P < ) LVEF40%BNPLVEF > 40% 3( P < ) BNP 7( P < ) 31BNP
3 NatlMed J China,May 9, 2006, Vol 86, No / () 1 () (mm) (mm) LVEF ( % ) BNP 3 ( ng/l) () / [ ] / [ ] 3 : : 3 P < ; 3, 2LVEF > 40%LVEF40% (/) () / (mm) (mm) LVEF ( % ) BNP ( ng/l) () () () () LVEF > 40 % 132 (81 /51) / [ ] LVEF 40% 111 (94 /17) / # # 31 6 # # [ ] 1 # 18 # 44 # 48 # 110 (72 /38) / [ ] (103 /30) / [ ] :LVEF > 40%, 3 P < 0. 05, # P < ;, P < 0. 05; P < NYHABNP BNP ( ng/l ) [ ] [ ] 3 NYHA I [ ] NYHA [ ] 3 NYHA [ ] 3 NYHA [ ] 3 # :, 3 P < ;NYHA, P < 01001; NYHA, P < ;NYHA, # P < : ROC ROC BNP, BNP,;, ROC(AUC) (4, 5) BNP( ) LVEF40% AUC> 019; LVEF > 40% (LVEF > 40%), AUC , ;LVEF > 40%LVEF40%AUC017018, BNP 9010 ng/l LVEF 40%, 9819% ; LVEF40% 4AUCBNP AUC 95% CI P vs < vs LVEF > 40% < vs LVEF40% < LVEF > 40%vs LVEF 40% < vs < vs < vs < BNP ( % ) BNP ( ng/l) vs vs LVEF > 40% vs LVEF40% LVEF > 40%vs LVEF 40% vs vs vs % 9815%, 9410%9615% BNP5010 ng/l LVEF > 40% 8810% 8417%, 7216%7211%
4 NatlMed J China,May 9, 2006, Vol 86, No117 LVEF40%, BNP 50 ng/l, 9710% 98% BNP,BNP BNP BNP 1. BNP :BNP Maisel [ 4 ] BNP37 ng/l 6 ng/l, BNP 572 ng/l 115 ng/l, BNPNYHA Joung [ 5 ], BNP,,2,,2,,, BNP,BNP,, BNP [ 6 ] BNP NYHA McDonagh [ 7 ] BNP,, BNP,, BNP LVEF40% (NYHA)BNP (NYHA ) 7 LVEF 40% BNP LVEF > 40% 3 Ry [ 8 ] NYHA BNP NYHA12, Fonseca [ 9 ] LVEF < 40%BNP LVEF > 40%, LVEF, BNP [ 10 ], BNP,,,mRNA BNP(108),BNP, BNP (NT2p robnp)bnp, BNP LVEF < 40% BNP 2. BNP: AUC,BNP, BNP LVEF40%(AUC = 01989)(AUC = 01991), LVEF > 40%LVEF40% (AUC = ) BNP LVEF, Fonseca [ 9 ] BNP LVEF > 40% LVEF 40%LVEF > 40%LVEF40% BNPLVEF40% (AUC: 9816% 9911% ),LVEF > 40%LVEF40% (AUC: 6313% 6316% ) LVEF40% 9010 ng/l, ; 9010 ng/l, Dao [ 11 ], BNP80 ng/l,98%, 92%, 90%, 98%, ROC 0197 LVEF > 40%,5010 ng/l, 8810% 8417% ; 7216%7211% ; 7914%7619%,,, BNP, 52 [ 12 ], BNP7614 ng/l, 93%,90% ; 1586 BNP [ 13 ], 100 ng/l BNP, 8314% 100 ng/l 9010 ng/l LVEF40% ;5010 ng/l
5 NatlMed J China,May 9, 2006, Vol 86, No LVEF > 40%, BNP BNP 50 ng/l, 9710%LVEF40% 9810%, Maisel [ 13 ] BNP (BN P < 50 ng/l ), 96% BNP,BNP [ 14 ] [ 15 ],, 1 Sudoh T, Kangawa K, M inam ino N, et al. A new natriuretic pep tide in porcine brain. Nature, 1988, 332: Mukoyama M, Nakao K, Saito Y, et al. Increased huan brain natriuretic pep tide in congestive heart failure. N Engl J Med, 1990, 323: Morrison KL, Harrison A, Krishnaswany P, et al. V tility of a rap id B2 natriuretic pep tide ( BNP ) assay in differentiating CHF from lung disease in patients p resenting with dyspnea. J Am Coll Cardiol, 2002, 39: Maisel AS, Koon J, Krishnaswamy P, et al. U tility of B2natriuretic pep tide as a rapid, point2of2care test for screening patients undergoing echocardiography to determ ine left ventricular dysfunction. Am Heart J, 2001, 141: Joung BY, Park BE, Kim DS, et al. B2type Natriuretic pep tide p redicts clinical p resentations and ventricular overloading in patients with Heart Failure. YonseiMedical J, 2003, 44: Groenning BA, N ilsson JC, Sondergaard L, et al: Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. European Jourmal of Heart Failure, 2001, 3: McDonagh TA, Robb SD, Murdoch DR, et al. B iochemical detection of left2ventricular systolic dysfunction. Lancet, 1998, 351: Ry SD, Clerico A, Giannessi D, et al. Measurement of brain natriuretic peptide in p lasma samples and cardiac tissue extracts by means of an immunoradiometric assay method. Scand J Clin Lab Invest, 2000, 60: Fonseca C, Sarmento PM, M ineza, et al. Comparative value of BNP and NT2p robnp in diagnosis of heart failure. Rev Port Cardiol, 2004, 23: de Bold AJ, B runeau BG, de Bold MLK. Mechanical and neuroendocrine regulation of the endocrine heart. Cariovasc Res, 1996, 31: Dao Q, Krishnaswarmy P, Kazanegra R, et al. U tility of B2type natriuretic peptide in the diagnosis of congestive heart failure in an urgent2care setting. J Am Coll Cardiol, 2001, 37: Davis M, Espiner E, R ichards G, et al. Plasma brain natriuretic pep tide in assessment of acute dyspnoea. Lancet, 1994, 343: Maisel AS, Krishnaswamy P, Nowak RM, et al. Rap id measurement of B2type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002, 347: Akiba T, Tachibana K, Togashi K, et al. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol, 1995, 44: S612S La V illa G, R iccardi D, Lazzeri C, et al. B lunted natriuretic response to low2dose brain natriuretic pep tide infusion in nonazotem ic cirrhotic patientswith ascites and avid sodium retention. Hepatology, 1995, 22: (: ) (:) 62, 5000, , ,,:,,,, 32,50, ( 1200,: , , )(15%)
A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: A multicenter evaluation
Congestive Heart Failure A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: A multicenter evaluation Stacey J. Wieczorek, PhD, a Alan H. B. Wu,
More informationESCBM meeting 2018, Prague Utility of Cardiac Biomarkers in Clinical Heart Failure Care. Md. Shahidul Islam, M.D., Ph.D
ESCBM meeting 2018, Prague Utility of Cardiac Biomarkers in Clinical Heart Failure Care Md. Shahidul Islam, M.D., Ph.D shaisl@me.com 2 3 Circulating Biomarkers in Heart Failure. Berezin AE. Adv. Exp. Med.
More informationClinical value of plasma B type natriuretic peptide assay in pediatric pneumonia accompanied by heart failure
EXPERIMENTAL AND THERAPEUTIC MEDICINE 10: 2175-2179, 2015 Clinical value of plasma B type natriuretic peptide assay in pediatric pneumonia accompanied by heart failure DAN HU 1*, YANG LIU 2*, HUIXIAN TAO
More informationNatriuretic Peptides The Cardiologists View. Christopher defilippi, MD University of Maryland Baltimore, MD, USA
Natriuretic Peptides The Cardiologists View Christopher defilippi, MD University of Maryland Baltimore, MD, USA Disclosures Research support: Alere, BG Medicine, Critical Diagnostics, Roche Diagnostics,
More informationBNP. Daniel J. Fink, MD, MPH Director, Core Laboratory New York Presbyterian Hospital Columbia University Medical Center New York, New York
Daniel J. Fink, MD, MPH Director, Core Laboratory New York Presbyterian Hospital Columbia University Medical Center New York, New York October 10, 2005 1 Outline The Biochemistry of Natriuretic Peptides
More informationB-Type Natriuretic Peptide Predicts Future Cardiac Events in Patients Presenting to the Emergency Department With Dyspnea
ORIGINAL CONTRIBUTION B-Type Natriuretic Peptide Predicts Future Cardiac Events in Patients Presenting to the Emergency Department With Dyspnea From the Division of Cardiology and General Internal Medicine
More information*Christian M. Carlsen, 1 Mette Mouridsen, 1 Ahmad Sajadieh, 1 Lars Køber, 2 Olav W. Nielsen 1 ABSTRACT BACKGROUND
USE OF N-TERMINAL NATRIURETIC PEPTIDE IN A REAL- WORLD SETTING OF PATIENTS ADMITTED WITH ACUTE DYSPNOEA AND THE IMPLICATION FOR TRIAGING PATIENTS IN THE EMERGENCY DEPARTMENT *Christian M. Carlsen, 1 Mette
More informationPlasma BNP as a Biomarker for Clinical Staging of Heart Failure MM Hoque 1, S Shafiullah 2, P Sultana 1
Plasma BNP as a Biomarker for Clinical Staging of Heart Failure MM Hoque 1, S Shafiullah 2, P Sultana 1 1 Department of Biochemistry, BSMMU, 2 Department of Biochemistry, Shaheed Suhrawardi Medical College.
More informationThe Role of Brain Natriuretic Peptide in the Patients with Acute Dyspnea in the Emergency Department
REVIEW Korean Circulation J 2007;37:464-469 ISSN 1738-5520 c 2007, The Korean Society of Cardiology The Role of Brain Natriuretic Peptide in the Patients with Acute Dyspnea in the Emergency Department
More informationIs B-type natriuretic peptide a risk factor for heart failure in patients treated with bardoxolone methyl?
University of Wollongong Research Online Illawarra Health and Medical Research Institute Faculty of Science, Medicine and Health 2015 Is B-type natriuretic peptide a risk factor for heart failure in patients
More informationB-type Natriuretic Peptide for Diagnosis of Heart Failure in Emergency Department Patients: A Critical Appraisal
686 Schwam d BNP FOR DIAGNOSIS OF HF B-type Natriuretic Peptide for Diagnosis of Heart Failure in Emergency Department Patients: A Critical Appraisal Abstract The diagnosis of heart failure in the outpatient
More informationA study of Brain Natriuretic Peptide levels in acute cardiac failure
Original Research Article A study of Brain Natriuretic Peptide levels in acute cardiac failure Bhavik Prajapati 1*, Anirudh Kulkarni 2 1 Assistant Professor, Department of Medicine, SMS Multispecialty
More informationThe Optimal Cut-off Value of Plasma BNP to Differentiate Heart Failure in the Emergency Department in Japanese Patients with Dyspnea
ORIGINAL ARTICLE The Optimal Cut-off Value of Plasma BNP to Differentiate Heart Failure in the Emergency Department in Japanese Patients with Dyspnea Kotaro Nakata 1, Kimiaki Komukai 1, Yutaka Yoshii 2,
More informationThe Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure?
The Who, How and When of Advanced Heart Failure Therapies 9 th Annual Dartmouth Conference on Advances in Heart Failure Therapies Dartmouth-Hitchcock Medical Center Lebanon, NH May 20, 2013 Joseph G. Rogers,
More informationJournal of the American College of Cardiology Vol. 41, No. 11, by the American College of Cardiology Foundation ISSN /03/$30.
Journal of the American College of Cardiology Vol. 41, No. 11, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00405-4
More informationThe Clinical Experiences of B-type Natriuretic Peptide Blood Concentrations for Diagnosis in Congestive Heart Failure
CASE REPORT IMAGE IN CARDIOVASCULAR MEDICINE REVIEW ARTICLE ORIGINAL ARTICLE Korean Circulation J 24;34(7):684-692 The Clinical Experiences of B-type Natriuretic Peptide Blood Concentrations for Diagnosis
More informationStudy of grading of severity of Heart Failure in patients with Dilated Cardiomyopathy
Original article: Study of grading of severity of Heart Failure in patients with Dilated Cardiomyopathy Dr Satyajeet Shantaram Nighute *, Dr Govind S. Shiddapur, Dr Madhulika Mahashaabde, Dr Chintan K.
More informationB-type natriuretic peptide (BNP): can it improve our management of patients with congestive heart failure?
Minireview Peer reviewed article SWISS MED WKLY 2002;132:618 622 www.smw.ch 618 B-type natriuretic peptide (BNP): can it improve our management of patients with congestive heart failure? Christian Mueller,
More information6/6/17. Heart Failure and Natriuretic Peptides. Learning objectives
Heart Failure and Natriuretic Peptides Maria-Magdalena Patru, MD, PhD Director, Medical and Scientific Affairs This promotional educational activity is brought to you by Ortho-Clinical Diagnostics, Inc.
More informationOverview & Update on the Utilization of the Natriuretic Peptides in Heart Failure
June 28, 2016 Overview & Update on the Utilization of the Natriuretic Peptides in Heart Failure Linda C. Rogers, PhD, DABCC, FACB. Agenda Overview of the Natriuretic Peptides and Efficacy studies Similarities
More informationOriginal Article. Β-Natriuretic Peptide Level as a Predictor for the Severity of LV Dysfunction. Summary:
BNatriuretic ΒNatriuretic (M.B.Ch.B, M.Sc.)* Hedef Dhafir ElYassin (Ph.D. Post Doctoral) ** Sabbah Yakoob ( M.B.Ch.B, M.R.C.P.) ** Summary: Fac Med Baghdad 2007; Vol.49, No.4 Received July 2006 Accepted
More informationREVIEW ARTICLE. A Systematic Review of the Diagnostic Accuracy of Natriuretic Peptides for Heart Failure
REVIEW ARTICLE A Systematic Review of the Diagnostic Accuracy of Natriuretic Peptides for Heart Failure Jenny A. Doust, BMBS, FRACGP; Paul P. Glasziou, FRACGP, PhD; Eva Pietrzak, PhD; Annette J. Dobson,
More informationDiagnostic value of N-terminal ProB-Type Natriuretic Peptide in Emergency Department: Analysis by subgroups
emergency care journal Diagnostic value of N-terminal ProB-Type Natriuretic Peptide in Emergency Department: Analysis by subgroups P. Villa, A. Dolci*, R. Dominici*, M. Panteghini**, C. Fundarò, S. Guzzetti
More informationTHE CORRELATION BETWEEN
THE CORRELATION BETWEEN NT Pro-BNP LEVELS AND ECHOCARDIOGRAPHIC FINDINGS IN A PATIENT WITH ACUTE ONSET DYSPNEA. Sonal Virani, Pavan Kumar. M, Sunil Dalvi 1. Assistant Professor, Department of General Medicine,
More informationBNP. Background. Natriuretic Peptides. Outline
Outline Daniel J. Fink, MD, MPH Director, Core aboratory New York Presbyterian Hospital Columbia University Medical Center New York, New York October 1, 25 The Biochemistry of Natriuretic Peptides Congestive
More informationClinical Investigation and Reports. B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure
Clinical Investigation and Reports B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure Analysis From Breathing Not Properly (BNP) Multinational Study Peter A. McCullough,
More informationTherapeutic Targets and Interventions
Therapeutic Targets and Interventions Ali Valika, MD, FACC Advanced Heart Failure and Pulmonary Hypertension Advocate Medical Group Midwest Heart Foundation Disclosures: 1. Novartis: Speaker Honorarium
More informationINTRODUCTION. Key Words:
Original Articles Acta Cardiol Sin 2008;24:29 34 Heart Failure Predicting Heart Failure Symptoms by Plasma N-terminal Pro B-Type Natriuretic Peptide for Patients with Chronic Aortic Regurgitation and Preserved
More informationNew in Heart Failure SGK autumn session 2012
New in Heart Failure SGK autumn session 2012 Roger Hullin Cardiology Department of Internal Medicine Centre Universitaire Hospitaler Vaudois University of Lausanne ESC Heart Failure Guidelines 2012 Classes
More informationJournal of the American College of Cardiology Vol. 44, No. 6, by the American College of Cardiology Foundation ISSN /04/$30.
Journal of the American College of Cardiology Vol. 44, No. 6, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.06.015
More informationEchocardiography. Measurement of BNP plasma levels. Statistical analysis. Echocardiographic classifications. 368 Maisel et al
Utility of B-natriuretic peptide as a rapid, point-ofcare test for screening patients undergoing echocardiography to determine left ventricular dysfunction Alan S. Maisel, MD, FACC, Jen Koon, BSN, Padma
More informationAntialdosterone treatment in heart failure
Update on the Treatment of Chronic Heart Failure 2012 Antialdosterone treatment in heart failure 전남의대윤현주 Chronic Heart Failure Prognosis of Heart failure Cecil, Text book of Internal Medicine, 22 th edition
More informationUniversity of Groningen. BNP and NT-proBNP in heart failure Hogenhuis, Jochem
University of Groningen BNP and NT-proBNP in heart failure Hogenhuis, Jochem IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationCopeptin in heart failure: Associations with clinical characteristics and prognosis
Copeptin in heart failure: Associations with clinical characteristics and prognosis D. Berliner, N. Deubner, W. Fenske, S. Brenner, G. Güder, B. Allolio, R. Jahns, G. Ertl, CE. Angermann, S. Störk for
More informationN-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
Eur Respir J 23; 22: 649 653 DOI: 1.1183/931936.3.2333 Printed in UK all rights reserved Copyright #ERS Journals Ltd 23 European Respiratory Journal ISSN 93-1936 N-terminal pro-brain natriuretic peptide
More informationThe right heart: the Cinderella of heart failure
The right heart: the Cinderella of heart failure Piotr Ponikowski, MD, PhD, FESC Medical University, Centre for Heart Disease Clinical Military Hospital Wroclaw, Poland none Disclosure Look into the Heart
More informationResearch on clinical value of galectin-3 in evaluating the prognosis
European Review for Medical and Pharmacological Sciences 2017; 21: 4406-4410 Research on clinical value of galectin-3 in evaluating the prognosis of acute heart failure T. ZHANG, B. SHAO, G.-A. LIU Cardiology
More informationThe role of remote monitoring in preventing readmissions after acute heart failure
The role of remote monitoring in preventing readmissions after acute heart failure October 20, 2017 Randall C Starling MD MPH FACC FAHA FESA FHFSA Professor of Medicine Kaufman Center for Heart Failure
More informationClinical applications of B-type natriuretic peptide (BNP) testing
European Heart Journal (2003) 24, 1710 1718 Review Clinical applications of B-type natriuretic peptide (BNP) testing M.R. Cowie a *, P. Jourdain b, A. Maisel c, U. Dahlstrom d, F. Follath e, R. Isnard
More informationJournal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30.
Journal of the American College of Cardiology Vol. 46, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.05.057
More informationAMINO-TERMINAL PRO-BRAIN NATRIURETIC PEPTID IN PREDICTION OF LEFT VENTRICULAR EJECTION FRACTION
& AMINO-TERMINAL PRO-BRAIN NATRIURETIC PEPTID IN PREDICTION OF LEFT VENTRICULAR EJECTION FRACTION Mugdim Bajrić¹, Fahir Baraković¹, Zumreta Kušljugić¹, Nermin Salkić¹, Elmir Jahić¹, Mensura Aščerić³*,
More informationDiagnosis and management of Chronic Heart Failure in 2018: What does NICE say? PCCS Meeting Issues and Answers Conference Nottingham
Diagnosis and management of Chronic Heart Failure in 2018: What does NICE say? PCCS Meeting Issues and Answers Conference Nottingham NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Chronic heart failure
More informationREVIEW ARTICLE. Accuracy of B-Type Natriuretic Peptide Tests to Exclude Congestive Heart Failure
REVIEW ARTICLE Accuracy of B-Type Natriuretic Peptide Tests to Exclude Congestive Heart Failure Systematic Review of Test Accuracy Studies Markus Battaglia, MD, MPH; Daniel Pewsner, MD; Peter Jüni, MD;
More informationCOPD as a comorbidity of heart failure in elderly patients
COPD as a comorbidity of heart failure in elderly patients Professor Mitja Lainscak, MD, PhD, FESC, FHFA Departments of Cardiology and Research&Education, General Hospital Celje Faculty of Medicine, University
More informationPrognostic Value of B-type Natriuretic Peptide for Assessment of Left Ventricular Function in Patients With Chronic Kidney Disease
Kidney Diseases Prognostic Value of B-type Natriuretic Peptide for Assessment of Left Ventricular Function in Patients With Chronic Kidney Disease Alireza Soleimani, 1 Omid Nasiri, 2 Hassan Nikoueinejad,
More informationTHE DIAGNOSTIC VALUE OF BNP AND LIGHT S CRITERIA ON HEART FAILURE IN PATIENTS WITH BILATERAL PLEURAL EFFUSION
Acta Medica Mediterranea, 2016, 32: 1779 THE DIAGNOSTIC VALUE OF BNP AND LIGHT S CRITERIA ON HEART FAILURE IN PATIENTS WITH BILATERAL PLEURAL EFFUSION BING LIU *,**, XUN DING ***, JIONG YANG *,** * Department
More informationHeart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output
Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover
More informationClinical Research on Brain Natriuretic Peptide Guiding the Application of 1 Receptor Blocker in Patients with Moderate to Severe Heart Failure
Original Article Acta Cardiol Sin 2015;31:52 58 doi: 10.6515/ACS20140728A Heart Failure Clinical Research on Brain Natriuretic Peptide Guiding the Application of 1 Receptor Blocker in Patients with Moderate
More informationClinical efficacy of ultrafiltration in the treatment of acute decompensated heart failure with diuretic resistance.
Biomedical Research 2017; 28 (14): 6155-6159 ISSN 0970-938X www.biomedres.info Clinical efficacy of ultrafiltration in the of acute decompensated heart failure with diuretic resistance. Jian Zhang, Qi
More informationUtility of B-Type Natriuretic Peptide in Predicting Postoperative Complications and Outcomes in Patients Undergoing Heart Surgery
Journal of the American College of Cardiology Vol. 43, No. 10, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.12.048
More informationObjectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009
Objectives Diastolic Heart Failure and Indications for Echocardiography in the Asian Population Damon M. Kwan, MD UCSF Asian Heart & Vascular Symposium 02.07.09 Define diastolic heart failure and differentiate
More informationRelationship between serum brain natriuretic peptide and heart function in patients with chronic kidney disease
The Korean Journal of Internal Medicine: 23:191-200, 2008 DOI: 10.3904/kjim.2008.23.4.191 Relationship between serum brain natriuretic peptide and heart function in patients with chronic kidney disease
More informationN atriuretic peptides are gaining increased recognition as
745 CARDIOVASCULAR MEDICINE The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population I Raymond, B A Groenning,
More informationΒΙΟΔΕΙΚΤΕΣ ΣΤΗΝ ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ. ΔΗΜΗΤΡΙΟΣ ΤΟΥΣΟΥΛΗΣ Καθηγητής Καρδιολογίας
ΕΘΝΙΚΟ ΚΑΙ ΚΑΠΟΔΙΣΤΡΙΑΚΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΑΘΗΝΩΝ ΙΑΤΡΙΚΗ ΣΧΟΛΗ Ά ΚΑΡΔΙΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ Διευθυντής: Καθηγητής Δημήτριος Τούσουλης ΒΙΟΔΕΙΚΤΕΣ ΣΤΗΝ ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ ΔΗΜΗΤΡΙΟΣ ΤΟΥΣΟΥΛΗΣ Καθηγητής Καρδιολογίας
More informationReview. Identification of circulating biomarkers that may provide. Natriuretic peptides in the diagnosis and management of heart failure.
Natriuretic peptides in the diagnosis and management of heart failure G. Michael Felker, John W. Petersen, Daniel B. Mark DOI:1503/cmaj.060236 Abstract The natriuretic peptides are a family of related
More informationHEART FAILURE IN WOMEN. Marian Limacher, MD Division of Cardiovascular Medicine University of Florida
HEART FAILURE IN WOMEN Marian Limacher, MD Division of Cardiovascular Medicine University of Florida Outline Epidemiology Clinical Overview Why HF is such a challenge State of the Field Heart Failure Adjudication
More informationHeart failure (HF) is a disabling condition with high
N-Terminal Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients Paulo Bettencourt, PhD; Ana Azevedo, MD; Joana Pimenta, MD; Fernando Friões, MD; Susana Ferreira,
More informationType of intervention Diagnosis. Economic study type Cost-effectiveness analysis.
The use of B-type natriuretic peptide in the management of patients with diabetes and acute dyspnoea Mueller C, Laule-Kilian K, Christ A, Perruchoud A P Record Status This is a critical abstract of an
More informationThe Art and Science of Diuretic therapy
The Art and Science of Diuretic therapy Dr. Fayez EL Shaer Associate Professour of cardiology Consultant cardiologist MD, MSc, PhD, CBNC, NBE FESC, ACCP, FASNC,HFA KKUH, KFCC Heart failure: fluid overload
More informationNT-proBNP: Evidence-based application in primary care
NT-proBNP: Evidence-based application in primary care Associate Professor Rob Doughty The University of Auckland, Auckland City Hospital, Auckland Heart Group NT-proBNP: Evidence in Primary Care The problem
More informationHeart failure (HF) is a complex clinical syndrome that results in the. impairment of the heart s ability to fill or to pump out blood.
Introduction: Heart failure (HF) is a complex clinical syndrome that results in the impairment of the heart s ability to fill or to pump out blood. As of 2013, an estimated 5.8 million people in the United
More informationMeasuring B-Type Natriuretic Peptide From Capillary Blood or Venous Sample: Is It the Same?
Elmer ress Original Article Cardiol Res. 2016;7(2):51-58 Measuring B-Type Natriuretic Peptide From Capillary Blood or Venous Sample: Is It the Same? Renato De Vecchis a, b, Carmelina Ariano a Abstract
More informationThe clinical value of natriuretic peptide testing in heart failure
The clinical value of natriuretic peptide testing in heart failure James L. Januzzi, Jr, MD, FACC, FESC Associate Professor of Medicine Harvard Medical School Roman W. DeSanctis Endowed Clinical Scholar
More informationB-Type Natriuretic Peptide and Cardiovascular Disease
Update B-Type Natriuretic Peptide and Cardiovascular Disease Luís Beck da Silva, Carlos A. Ferreira, Celso Blacher, Paulo Leães, Haissam Haddad Porto Alegre, RS / Ottawa, ON - Canadá Cardiologists and
More informationPost Hoc Analysis of the PARADIGM Heart Failure Trial:
Post Hoc Analysis of the PARADIGM Heart Failure Trial: Pulse Pressure and Outcomes in Heart Failure with Reduced Ejection Fraction Chen-Huan Chen, M.D. Professor, Department of Medicine, National Yang-Ming
More informationThe Treatment Targets in Acute Decompensated Heart Failure
SUCCESS WITH HEART FAILURE The Treatment Targets in Acute Decompensated Heart Failure Gregg C. Fonarow, MD The Ahmanson-UCLA Cardiomyopathy Center, Division of Cardiology, UCLA School of Medicine, Los
More informationΜαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό
Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling
More informationInfluence of Paroxysmal Atrial Fibrillation Attack on Brain Natriuretic Peptide Secretion
Influence of Paroxysmal Atrial Fibrillation Attack on Brain Natriuretic Peptide Secretion Keizo Kazuhiko TSUCHIDA,MD TANABE, MD Abstract Objectives. Plasma brain natriuretic peptide BNP concentration is
More informationCitation for published version (APA): Lok, D. J. A. (2013). Novel markers in chronic heart failure. Groningen: s.n.
University of Groningen Novel markers in chronic heart failure Lok, Dirk Jan Arend IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationValue of echocardiography in chronic dyspnea
Value of echocardiography in chronic dyspnea Jahrestagung Schweizerische Gesellschaft für /Schweizerische Gesellschaft für Pneumologie B. Kaufmann 16.06.2016 Chronic dyspnea Shortness of breath lasting
More informationBNP as a Predictor of Cardiovascular Disease and All Cause Mortality. Dr. Thierry Le Jemtel
BNP as a Predictor of Cardiovascular Disease and All Cause Mortality Dr. Thierry Le Jemtel Outline Role of BNP and probnp as relevant biomarkers in cardiac conditions Role of BNP and probnp as relevant
More informationHeart Failure Guidelines For your Daily Practice
Heart Failure Guidelines For your Daily Practice Juan M. Aranda, Jr., MD, FACC, FHFSA Professor of Medicine Director of Heart Failure and Cardiac Transplantation University of Florida College of Medicine
More informationSetting The setting was primary care. The economic study was carried out in the UK.
The use of brain natriuretic peptide as a screening test for left ventricular systolic dysfunction: cost-effectiveness in relation to open access echocardiography Sim V, Hampton D, Phillips C, Lo S N,
More informationB-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation
European Heart Journal (2005) 26, 234 240 doi:10.1093/eurheartj/ehi033 Clinical research B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain
More informationThe burden of disease in patients with. What s New. Heart Failure? In this article:
What s New in Heart Failure? A large part of the population is at risk for congestive heart failure. With one-year mortality rates approaching 40%, it is crucial to understand the newest and best treatment
More informationNT-proBNP A New Test for Diagnosis, Prognosis and Management of Congestive Heart Failure
Reference Section NT-proBNP A New Test for Diagnosis, Prognosis and Management of Congestive Heart Failure a report by Drs Rahul Sakhuja and James L Januzzi Cardiology Division and Department of Medicine,
More informationBiomarker-guided HF: What have we learned (so far)?
Biomarker-guided HF: What have we learned (so far)? James L. Januzzi, Jr, MD, FACC, FESC Associate Professor of Medicine Harvard Medical School Director, Cardiac ICU Massachusetts General Hospital DECLARATION
More informationLeft Ventricular Dysfunction Without Brain Natriuretic Peptide Elevation:
J Cardiol 2007 Mar; 49 3 : 149 153 2 Left Ventricular Dysfunction Without Brain Natriuretic Peptide Elevation: Two Case Reports Yuko Hajime Tomoharu Yasumichi Takeya Shunsuke Shohei Shuji Junichi TOGANE,
More informationHeart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)
Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types
More informationjournal of medicine The new england Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea abstract
The new england journal of medicine established in 1812 february 12, 2004 vol. 350 no. 7 Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea Christian Mueller, M.D., André
More informationProtocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year
PAST MEDICAL HISTORY Has the subject had a prior episode of heart failure? o Does the subject have a prior history of exposure to cardiotoxins, such as anthracyclines? URGENT HEART FAILURE VISIT Did heart
More informationSCOMPENSO CARDIACO: IL PUNTO DELLA RICERCA
Journal Club 19 Marzo 2010 SCOMPENSO CARDIACO: IL PUNTO DELLA RICERCA Alessandro Giordano Prevalence of heart failure by sex and age (NHANES:1999-2004) Circulation 2007 Incidence of heart failure by age
More informationAkash Ghai MD, FACC February 27, No Disclosures
Akash Ghai MD, FACC February 27, 2015 No Disclosures Epidemiology Lifetime risk is > 20% for American s older than 40 years old. > 650,000 new cases diagnosed each year. Incidence increases with age: 2%
More informationClinical Review Criteria Galectin-3 Blood Assay Test
Clinical Review Criteria Galectin-3 Blood Assay Test Kaiser Foundation Health Plan of Washington NOTICE: Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options,
More informationSleep Disordered Breathing and HH with Preserved Ejection Fraction:
Sleep Disordered Breathing and HH with Preserved Ejection Fraction: Pr Thibaud DAMY Heart Failure Unit Department of Cardiology CHU Mondor, Créteil, France Definition of HF-PEF The diagnosis of HF-PEF
More informationORIGINAL INVESTIGATION. Clinical Uncertainty, Diagnostic Accuracy, and Outcomes in Emergency Department Patients Presenting With Dyspnea
ORIGINAL INVESTIGATION Clinical Uncertainty, Diagnostic Accuracy, and Outcomes in Emergency Department Patients Presenting With Dyspnea Sandy M. Green, MD; Abelardo Martinez-Rumayor, MD; Shawn A. Gregory,
More informationHigh diagnostic accuracy of NT-proBNP for cardiac origin of pleural. effusions
ERJ Express. Published on February 15, 2006 as doi: 10.1183/09031936.06.00113205 High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions Martin Kolditz 1, MD; Michael Halank 1, MD;
More informationΧριστίνα Χρυσοχόου Καρδιολόγος Επι,Α Καρδιολογική Κλινική Πανεπιστηίου Αθηνών, ΙΓΝΑ
Χριστίνα Χρυσοχόου Καρδιολόγος Επι,Α Καρδιολογική Κλινική Πανεπιστηίου Αθηνών, ΙΓΝΑ Digitalisis a genus of about 20 species of herbaceousperennials, shrubs, and biennialsthat are commonly called foxgloves.
More informationKey words: brain natriuretic peptide; central sleep apnea; Cheyne-Stokes respiration; congestive heart failure
Brain Natriuretic Peptide in Patients With Congestive Heart Failure and Central Sleep Apnea* Carmen Carmona-Bernal, MD; Esther Quintana-Gallego, MD; Manuel Villa-Gil, PhD; Angeles Sánchez-Armengol, MD;
More informationHFpEF. April 26, 2018
HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes
More informationHeart Failure Clinician Guide JANUARY 2016
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.
More informationHeart 101. Objectives. Types of Heart Failure How common is HF? Sign/Symptoms, when to see a doctor? Diagnostic testing
EXAMING HEART FAILURE: HOW TO RECOGNIZE AND TREAT THE WEAK HEART What is Heart Failure? Treatment of Heart Failure End Stage Heart Failure Munir S. Janmohamed M.D. FACC Assistant Clinical Professor of
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationUpdate on Biomarkers in Heart Failure. Professor T A McDonagh, King s College Hospital. London
Update on Biomarkers in Heart Failure Professor T A McDonagh, King s College Hospital. London Known Knowns,,,, for Biomarkers in HF Natriuretic Peptides Troponins BNP... ANP/BNP/ in CHF First to be discovered
More informationPredictive Power of the Baseline QRS Complex Duration for Clinical Response to Cardiac Resynchronisation Therapy
CARDIAC RESYNCHRONISATION THERAPY ORIGINAL ARTICLE Predictive Power of the Baseline QRS Complex Duration for Clinical Response to Cardiac Resynchronisation Therapy Ali Kazemisaeid, MD, Ali Bozorgi, MD,
More informationNew NICE Heart Failure Guidelines What do they mean for primary and secondary care, and patients?
New NICE Heart Failure Guidelines 2018 - What do they mean for primary and secondary care, and patients? Prof Ahmet Fuat PhD FRCGP FRCP PG Dip (Cardiology) GP & GPSI Cardiology Darlington Professor of
More informationAdvanced Echocardiography in the Evaluation of Chemotherapy Patients
Advanced Echocardiography in the Evaluation of Chemotherapy Patients Juan Carlos Plana, MD, FACC, FASE Co-Director, Cardio-Oncology Center Section of Cardiovascular Imaging Department of Cardiovascular
More informationTreating HF Patients with ARNI s Why, When and How?
Treating HF Patients with ARNI s Why, When and How? 19 th Annual San Diego Heart Failure Symposium for Primary Care Physicians January 11-12, 2019 La Jolla, CA Barry Greenberg M.D. Distinguished Professor
More informationB-Type Natriuretic Peptide Levels in Obese Patients With Advanced Heart Failure
Journal of the American College of Cardiology Vol. 47, No. 1, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.08.050
More information